Discriminant analysis applied to SAR studies using topological descrip
tors allows us to plot frequency distribution diagrams: a function of
the number of drugs within an interval of values of discriminant funct
ion vs. these values. We make use of these representations, pharmacolo
gical distribution diagrams (PDDs), in structurally heterogeneous grou
ps where generally they adopt skewed Gaussian shapes or present severa
l maxima. The maxima afford intervals of discriminant function in whic
h exists a good expectancy to find new active drugs. A set of beta-blo
ckers with contrasted activity has been selected to test the ability o
f PDDs as a visualizing technique, for the identification of new beta-
blocker active compounds. (C) 1996 by Elsevier Science Inc.